Cancer and non-cancer brain and eye effects of chronic low-dose ionizing radiation exposure by Eugenio Picano et al.
Picano et al. BMC Cancer 2012, 12:157
http://www.biomedcentral.com/1471-2407/12/157REVIEW Open AccessCancer and non-cancer brain and eye effects of
chronic low-dose ionizing radiation exposure
Eugenio Picano1*, Eliseo Vano2, Luciano Domenici3, Matteo Bottai4 and Isabelle Thierry-Chef5Abstract
Background: According to a fundamental law of radiobiology (“Law of Bergonié and Tribondeau”, 1906), the brain
is a paradigm of a highly differentiated organ with low mitotic activity, and is thus radio-resistant. This assumption
has been challenged by recent evidence discussed in the present review.
Results: Ionizing radiation is an established environmental cause of brain cancer. Although direct evidence is
lacking in contemporary fluoroscopy due to obvious sample size limitation, limited follow-up time and lack of
focused research, anecdotal reports of clusters have appeared in the literature, raising the suspicion that brain
cancer may be a professional disease of interventional cardiologists. In addition, although terminally differentiated
neurons have reduced or mild proliferative capacity, and are therefore not regarded as critical radiation targets,
adult neurogenesis occurs in the dentate gyrus of the hippocampus and the olfactory bulb, and is important for
mood, learning/memory and normal olfactory function, whose impairment is a recognized early biomarker of
neurodegenerative diseases. The head doses involved in radiotherapy are high, usually above 2 Sv, whereas the
low-dose range of professional exposure typically involves lifetime cumulative whole-body exposure in the low-
dose range of< 200 mSv, but with head exposure which may (in absence of protection) arrive at a head equivalent
dose of 1 to 3 Sv after a professional lifetime (corresponding to a brain equivalent dose around 500 mSv).
Conclusions: At this point, a systematic assessment of brain (cancer and non-cancer) effects of chronic low-dose
radiation exposure in interventional cardiologists and staff is needed.
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The characterization of health effects (cancer and non-
cancer) of chronic low-dose radiation (LDR) is still in-
complete and difficult. The UNSCEAR (United Nations
Scientific Committee on the Effects of Atomic Radiation)
2009 clearly recommends paying more attention “to
other non-cancer disease entities, in addition to circula-
tory diseases”, encouraging “future epidemiological stud-
ies designed to assess clinical and subclinical endpoints,
as well as biomarkers, since this information is more
likely to lead to insights” [1]. In 2006 the National Academy
of Sciences BEIR VII committee identified as one of the top
ten research needs “future occupational radiation studies”,
which should include highly exposed populations with full
record of exposure and well-suited to assessing the effects* Correspondence: picano@ifc.cnr.it
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reproduction in any medium, provided the origof long-term, low-level radiation exposure in humans [2].
The International Commission on Radiological Protection
(ICRP) stated in 2011 that “particular attention should be
paid to radiation effects in the lens of the eye and on the
cardiovascular system, because of recent published observa-
tions of radiation effects in these systems occurring at much
lower doses than reported previously”, and that brain ir-
radiation can have direct radiation effects on the thyroid
and pituitary glands, as well as subtle effects on the hypo-
thalamic-pituitary-adrenal axis and the hypothalamic, pitu-
itary-gonadal axis [3].
Within the general framework of the still-elusive assess-
ment of cancer and non-cancer effects of LDR, high and
unprecedented levels of radiation exposure in the contem-
porary population of interventional cardiologists and other
paramedical staff working at the catheterization laboratory
clearly represent a challenge and an opportunity, especially
if we wish to characterize the brain effects of LDR. The
brain is a paradigm of a highly differentiated organ withLtd. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
Figure 1 (a) The range of radiation exposure of interventional
cardiologists per single procedure: diagnostic coronary
angiography, percutaneous coronary angioplasty, cardiac
ablation, cardiac pacemakers, intracardiac defibrillator or
implantation, transcutaneous aortic valve implantation, dilation
of chronic coronary total occlusion and endovascular thoraco-
abdominal aneurysm repair. From original data of references 14–
16. There is substantial variability in operator dose across procedures
and within each procedure. On the y-axis, a log scale is used. Right
side: The annual radiation exposure for different specialists.
Interventional cardiologists are by far the most exposed (modified
from Vano E et?al., 1998, ref. 4). (b) The map of radiation exposure in
the cardiac interventionalist. There are “hot regions” of higher
exposure in the eye, thyroid and brain that should be carefully
protected by glasses, collars and cap. Radiation exposure on the left
is almost double that on the right side (modified from Vano E et?al.,
1998, ref. 4). Right side: Estimated cumulative dose after 20 years of
professional life in the cardiac cath lab: the whole body dose (below
lead apron) is around 100 mSv; the head dose is 10 times higher,
and in the head, the left head dose is twice that of the right side
dose. Obviously, in this order of magnitude there are substantial
variations (up to 10 times) depending on years of exposure, volume
of activity, type of procedure, technology used, protection habits
and radiation awareness.
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ing to a fundamental law of radiobiology (“law of Bergonié
and Tribondeau”, 1906). In fact, the brain is one of the main
target organs of radiation exposure in the catheterization
lab [4,5], and is usually unprotected due to the myth of its
radio-resistance [6]. The brain and head effects of LDR may
include stochastic and deterministic effects. Stochastic or
probabilistic effects of low-dose radiation consist primarily
of cancer, which is the main effect recognized at a regula-
tory and radioprotection level [7]. In theory, stochastic
effects may well include other non-cancer effects such as
neuro-vascular and neuro-degenerative effects, for which
there is clear experimental evidence [8]. Another clinically
relevant radiation effect on the head is eye cataract, previ-
ously thought to be deterministic (tissue reactions) and cur-
rently recognized as possibly stochastic in nature, and
occurring at much lower radiation exposure level than
previously thought [9]. In general, there is a striking lack
of evidence systematically collected in exposed medical
professionals.
Radiation exposure of interventional cardiologists
Medical radiation from x-rays and nuclear medicine is the
largest manmade source of radiation exposure in Western
countries, accounting for a mean effective dose of 3.0 mSv
per capita per year, corresponding to a cardiological risk of
150 chest x-rays [10,11]. Of this equivalent 150 chest x-rays
from medical radiation (except radiotherapy), almost one-
half come from cardiology procedures [11]. Interventional
radiology and interventional cardiology account for about
14% (0.43 of 3.0 mSv) of overall exposure to the average US
citizen for the radiological year 2006 [11]. Each procedure
involves a relatively large radiation exposure for the patient,
which in each exam may range from 7 to 56 mSv, around
an average reference dose of 15 mSv for a percutaneous
coronary intervention or a cardiac radiofrequency ablation
[12]. The high levels of patient exposure also imply a signifi-
cant professional exposure for the interventional cardiolo-
gist, who needs to operate near the patient and the
radiation source. The single dose per procedure of the oper-
ator is on the order of magnitude of one thousandth of the
exposure of the patient [13] (Figure 1a). Effective occupa-
tional doses per procedure range from 0.02 to 38 microSv
for diagnostic catheterization, 0.2 to 31.2 microSv for percu-
taneous coronary intervention, 0.2–9.6 microSv for abla-
tion, 0.3–17.4 microSv for pacemaker or intracardiac
defibrillation implantations [14] and may reach even higher
values per procedure up to 50 microSv for dilation of
chronic total occlusion and up to 100 microSv transcutane-
ous aortic valve [15] and up to 200 microSv per single pro-
cedure of endovascular thoraco-abdominal aneurysm repair
[16]. The measurement over personal protective devices
ranged from 0.4–1,100 microSv at the eye level, 1.2–580
microSv at the thyroid level, 32–750 microSv at the trunklevel, and 0.4–790 microSv at head level, whereas measure-
ments under the apron at the trunk levels ranged from 0 to
23 microSv [14]. Each operator does hundreds or thou-
sands of procedures each year, and therefore the cumula-
tive dose in a professional lifetime is not negligible. The
most active and experienced interventional cardiologists in
Figure 2 The dose-effect relationship between radiation exposure and cancer (left side) and radiation exposure and atherosclerosis
(right side). The solid line indicates the epidemiological evidence, which is conclusive for cancer risk above 50 mSv and for atherosclerosis risk
above 500 mSv. The dashed line indicates the dose range with absent or inconclusive evidence. Freely adapted from refs 3 (BEIR VII, 2006) and 7
(ICRP publication 103, 2007).
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to around 5 mSv (below apron) per year, two to three times
higher than that of diagnostic radiologists [4] (Figure 1b)
and a projected professional lifetime attributable excess
cancer risk of 1 in 100 [17]. Of special concern, in interven-
tional cardiologists the head organ dose is 10- to 20-fold
higher than the dose recorded beneath the apron [18,19]
(Figure 2). Annual exposure to the cardiologist's head is
on the order of magnitude of 100 microsieverts per single
ablation procedure [18] and in the range of 20–30 mSv
per year [19] or much higher if a ceiling-suspended screen
is not used [20,21]. Radiation from the fluoroscopy tube is
scattered by the patient while the cardiac intervention is
underway and can reach the physician’s head, which is
often unprotected, even if a lead apron is worn to protect
the torso. The left side of the operator is more exposed
than the right side in most cases due to the usual layout of
an interventional room, where the radiologist or cardiolo-
gist operates from the right side of the patient. Scattered
radiation comes from the patient and is more intense
when the x-ray tube is on his/her left. This implies that
the lifetime estimated organ dose for a busy interventional
cardiologist after 25 years of work in the catheterization la-
boratory is in the order of magnitude of 1 to 3 Sv as scatterdose measured at the head with a dosimeter and the brain
dose that could approximately be a 20–25% of the “external
dose” (Figure 2). Unfortunately, the practice of interven-
tional cardiology is sometimes accompanied by suboptimal
perception of radiation risk and by negligent use of radi-
ation protection tools [22-24]. Radioprotection awareness
by operators is dramatically effective in reducing profes-
sional exposure by 90% [20]. Today, in most cardiology
imaging laboratories and in interventional radiology fluor-
oscopy rooms, overhead radiation shields, thyroid shields,
and leaded aprons are employed to reduce the radiation
doses to the operators head and neck. It is rare that unpro-
tected radiologists or cardiologist would do an angiog-
raphy procedure. Unfortunately, this was not the most
common situation in the past, and still today is not the
rule in all and every laboratory [22-24].
Brain cancer risk
The central dogma of radioprotection is that biological
effects of ionizing radiation are a direct consequence of
DNA damage occurring in directly irradiated cells. This
remains a useful approach in radioprotection, although in
experimental models of mice medulloblastoma, brain can-
cer increases in spite of lead shields for protecting mouse
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probably linked to soluble factors released by irradiated
cells [25]. In addition to the absorbed dose and type of ra-
diation, the probability of stochastic effects varies depend-
ing on the organ or tissue irradiated. To calculate the
effective dose, the individual organ dose values (equivalent
doses) are multiplied by the respective dimensionless tis-
sue weighing factor. In radiation protection, the tissue
weighting factor is a factor weighting the equivalent dose
in a particular tissue or organ in terms of its relative con-
tribution to the total deleterious effects resulting from uni-
form irradiation of the whole body. In other words, the
higher this factor, the more radiosensitive the tissue. The
ICRP has offered recommended tissue weighting factors in
three reports, their Publication 26 (1977) [26], Publication
60 (1991) and the most recent Publication 103 (2007) [7].
The key changes introduced in ICRP Publication 103 are a
140% increase in breast risk factor from 0.05 to 0.12 (a
value similar to colon, lung, stomach and red bone mar-
row, all considered highly radiosensitive tissues) and a de-
crease in gonad weighting from 0.20 to 0.08 (Table 1). In
2007, brain tissue was given more weight and received
0.01 of weighting factor, whereas it was clustered among
the remainder (with 14 other tissues) in the 1991 version.
A similar trend was shown for the salivary glands, which
may also suffer from high head irradiation in catheterization
laboratory workers.
Shifting from a radioprotection to an oncology perspec-
tive, ionizing radiation is one of the few established causes








Bladder _ _ _ 0.05 0.04
Bone 0.03 0.01 0.01
Brain _ _ _ _ _ _ 0.01
Breasts 0.15 0.05 0.12
Colon _ _ _ _ _ _ 0.12
Esophagus _ _ _ 0.05 0.04
Liver _ _ _ 0.05 0.04
Lower large intestine _ _ _ 0.12 _ _ _
Lungs 0.12 0.12 0.12
Ovaries/testes 0.25 0.20 0.08
Red marrow 0.12 0.12 0.12
Remainder tissues 0.30 0.05 0.12
Salivary glands _ _ _ _ _ _ 0.01
Skin _ _ _ 0.01 0.01
Stomach _ _ _ 0.12 0.12
Thyroid 0.05 0.04
Adapted from refs 7, 26 and 27.develop benign and malignant tumors after diagnostic X-
rays was shown in several case–control studies, four of
them from dental exposures, and with relative risks ran-
ging from 1.6 to 10 [27]. Studies of the incidence of ner-
vous system tumors in atomic bomb survivors concluded
that exposure to radiation doses of less than 1 Sv is asso-
ciated with an increased incidence of nervous system
tumors [28]. A review of cohort mortality studies among
workers exposed to ionizing radiation in U.S. nuclear pro-
grams was reported in 1991 and reappraised in 2001 [29],
with 3.8 person-years of observation among 140,000 white
male workers. The increased risk of brain tumor was
highly consistent, persistent, and stable, on the order of
magnitude of 15–30%. As a consequence of these data,
policy makers have identified brain cancer as a "specified"
cancer potentially related to occupational exposures under
the Energy Employees Occupational Illness Compensation
Program Act [30]. Cosmic radiation can also probably pro-
voke brain tumors. In a large German cohort of 6,017
cockpit and 20,757 cabin crew members, Zeeb et al.
reported an increased fatal brain tumor risk among cock-
pit (not cabin) crew, with the relative risks of 1, 2.49 and
3.56 for workers with 10–20 years, 20–30 years, and> 30
years duration of employment, respectively [31].
Epidemiologic evidence for radiation-induced brain can-
cer in fluoroscopists is suggestive, but by no means conclu-
sive (Table 2) [32-40]. One study [32] found that the death
rate from brain cancer in radiologists was almost three
times that of other medical specialists who did not use radi-
ation. A case–control study [37] of 233 patients with brain
tumors reported that work as a physician with use of fluor-
oscopy increased the risk of developing a brain tumor, with
an odds ratio of 6.0 (95% CI, 0.62–57.7), although there
were only three such individuals among the 233 cases. An-
other case–control study [35] of 476 individuals diagnosed
with glioma also observed an increased risk in physicians
and surgeons (odds ratio, 3.5; 95% CI, 0.7–17.6). However,
such studies cannot exclude other biologic agents and che-
micals unrelated to radiation as causative, and other case–
control studies failed to identify a significant risk of brain
tumors as a result of a generic exposure to medical ionizing
radiation [38]. Essentially, no data are available on the con-
temporary population of invasive fluoroscopists, whose level
and pattern of head exposure is unprecedented, although
some anecdotal clusters of brain cancer have been recently
described [39,40]. Of particular interest, the most recent de-
scription of three brain gliomas and one meningioma in
interventional cardiologists all involved the left side, known
to be more exposed than the right side, although no brain
radiation dose was provided for any of these cases [40].
In general, we should consider some important methodo-
logical aspects: 1) timing of studies; 2) sample size; 3) chan-
ging levels of exposure [41,42]. Most studies were conducted
at a time when interventional cardiology was still a relatively
Table 2 Reports of brain cancer incidence in physicians, radiologists and interventionalists
STUDY, YEAR METHODS FINDINGS
Matanoski et al., 1975 [32] Cohort study of mortality in 6,500 US male radiologists
(years first worked 1920–1969) over a 50-year period
Excess cancer risk among radiologists compared with other
physicians
Wang JX et al., 1990 [33] Cohort study of Chinese diagnostic x-ray workers
(1950 to 1985)
Trend of excess cancer risk (standardized incidence ratio
1.2 for employment duration 10–14 years; 2.3 for
15–19 years) compared to non-radiation medical workers,
not available for brain cancer
Andersson M et al., 1991 [34] Cohort study of Danish radiation therapy workers Trend of excess cancer risk (standardized incidence ratio
1.09 with measured radiation dose< 5 mSv, and 2.23 with
dose 5–50 mSv), not available for brain cancer
Carozza et al., 2000 [35] Case–control study of occupation and glioma Physicians at increased, albeit imprecise, risk of glioma
(OR 3.5, CI 0.7- 17)
Andersen M et al., 1999 [36] Population-based study of occupation and cancer
incidence (from the 1990s to 1980s)
Brain cancer increased among physicians in general; no
breakdown by specialty
Hardell et al., 2001 [37] Case control study of 233 gliomas Excess cancer risk of 6.0 in fluoroscopists
Blettner et al., 2007 [38] Case control study of German patients (age
30–59 years at diagnosis) with brain cancer in
2001–2003
Occupational exposure (physicians, nurses, radiographers)
with OR 2.49 (0.74–8.38) for neurinoma, OR close to 1 for
glioma and meningioma
Finkelstein et al., 1998 [39] Report of a case cluster (1990s) Brain cancer in two interventionalists
Roguin et al., 2012 [40] Report of a case cluster (2000s) 3 brain gliomas and 1 meningioma, left-sided, in 4
interventional cardiologists
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today. For most known carcinogens, identification of
increased risk of solid tumors (particularly brain tumors) has
required long follow-up periods of subjects with substantial
exposure. For example, while the atomic bombs were
dropped on Hiroshima and Nagasaki in August 1945, an ex-
cess risk of solid tumors was reported in the survivors only
in the 1960s, and no elevation in risk of brain tumors was
noted for about 50 years [28]. Another important issue is
that exposure from interventional cardiology is very asym-
metrical, with the left side twice more exposed that the right
side [4,13]. The risk, if it exists, is therefore likely to be more
pronounced on the left side. Therefore, studies now at the
starting blocks should enroll a well-characterized population
of catheterization lab workers, record all (including non-fatal
and non-malignant) cases of brain cancer and other non-
brain head cancers, such as salivary glands, and assess the
possible asymmetry of incidence (left- side cases being pos-
sibly more frequent than right-sided cases) mirroring the
asymmetry of dose exposure.
Another potentially useful approach is the use of registry
data. In some countries of Europe and the US, there are
updated and reliable registries that can link occupational
exposure with death and hospitalization records for a large
number of individuals exposed many years ago [36,38].
Radiation exposure and vascular disease
Systematic reviews of the published epidemiological lit-
erature and cardiovascular disease [43,44], or reviews of
studies of populations medically, occupationally or envir-
onmentally exposed to relatively low-dose radiation [45-
47] concluded that there is a significant association(although with substantial heterogeneity) between radi-
ation exposure and circulatory disease, either cardiovas-
cular or cerebrovascular. Vascular injury is a well-
recognized cause of late radiation-therapy morbidity and
this manifests as atherosclerosis in large vessels [7,8].
There is a significant increase in localized atherosclerosis
after radiotherapy for head and neck cancer and this
results in an excess risk of cardiovascular disease and
stroke, which is increasingly evident with long follow-up
(> 10 years) [43]. From current evidence, according to
ICRP 2011 a judgement can be made regarding a thresh-
old acute dose of about 0.5 Gy (or 500 mSv) for both
cardiovascular disease and cerebrovascular disease [3]
(Figure 3). On that basis, “0.5 Gy may lead to approxi-
mately 1% of exposed individuals developing the disease
in question, more than 10 years after exposure. This is in
addition to the high natural incidence rate (circulatory
disease accounts for 30–50% of all deaths in most devel-
oped countries)." [3]. This dose threshold can be reached
by an interventional cardiologist in his/her professional life
as head dose and by a patient during some complex inter-
ventional procedures [3]. Several biological mechanisms
exist which might be responsible for linking radiation ex-
posure to atherosclerosis. A relatively recent paradigm
states that atherosclerosis is an inflammatory disease of
the arteries that can lead to ischemia of the heart and
brain, resulting in infarction. Chronic inflammation of the
artery is initiated by endothelial dysfunction that may be
caused, for example, by elevated low-density lipoproteins,
and free radicals. The chronic inflammation results in
altered function of macrophages and lymphocytes, whose
activation causes the release of cytokines and growth
Figure 3 The modified cellular and pathophysiological model leading to neurodegenerative and atherosclerotic disease through
possibly shared molecular pathways. Modified from ref. 48.
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and cell aging, cell apoptosis, local necrosis, and altered
blood flow [48] (Figure 3). Clinical laboratory data from
the clinical Adult Health Study subset also provide some
insight into subclinical changes underlying disease devel-
opment, such as an increased amount of aortic arch calci-
fication [49], dose-dependent increases in longitudinal
trends for systolic and diastolic blood pressure [50], serum
cholesterol levels [51], and dose-related increase in serum
levels of various inflammation markers among the cohort
subjects, including C-reactive protein, interleukin-6 andFigure 4 The cellular and experimental effects of x-ray on adult brain
olfactory bulb (left upper panel, A); environmental factors can positively (en
(right upper panel, B); of many physical, chemical and genetic factors modu
neurogenesis (left lower panel, C). The inhibition of neurogenesis in a mou
chronic rather than with acute exposures (right lower panel, D, modified frosialic acid [52], with decreases in proportion of CD4+ T-
cells in the peripheral blood lymphocytes, suggesting a role
of radiation-induced immunity in promotion of pre-clin-
ical inflammation [53].
Radiation effects on the vascular system are not limited
to macrovessels such as carotid arteries but may also in-
volve small arterioles and microcirculatory function in
vessels too small to be imaged by angiography [54,55]. It
is now well-recognized that many of the same risk fac-
tors that cause heart disease also can lead to vascular de-
mentia in the elderly [56] and microvascular brain. Adult neurogenesis occurs in the caudate nucleus, hippocampus and
vironmental enrichment) or negatively modulate adult brain plasticity
lating plasticity, x-rays are a recognized potent inhibitor of
se model is more striking in males than in females, and with repetitive,
m ref 70, Silasi et al.).
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arteries and the progressive mismatch of their cross-talk
with small cerebral arteries – a potent risk factor for
cognitive decline and the onset of dementia in older
individuals [57]. Morphological and functional altera-
tions of the dermal microcirculation identified by capil-
lary microscopy have been identified in 145 physicians
exposed to low-dose ionizing radiation (radiologists, car-
diologists and orthopaedic specialists) compared to 105
non-exposed controls [58]. The combination of macro-
and micro-vascular damage can thus, in principle, exert
negative effects on the neurovascular and neurocognitive
function of subjects exposed to ionized radiation.
Neurocognitive effects: direct radiation effects on neural
cells
Terminally differentiated neurons have reduced or null
proliferative capacity, so they have not been traditionally
regarded as critical radiation targets. However, tissue tol-
erance of the normal brain to radiation therapy is very
limited and radiation doses have to be tailored to
minimize the deleterious effects on the nervous system
[59]. Of special interest, cognitive decline in patients
with radiological abnormalities (white matter hyperinten-
sities and global cortical atrophy) was associated with
radiotherapy doses that are considered safe (< 2 Sv) [60].
There are four possible cellular targets of radiation dam-
age: endothelial cells, which are sensitive to radiation
damage although they may recover after initial reduction
in cell number [61]; oligodendroglial stem cells, which
represent 75% of the cycling cells in the human brain
and are permanently destroyed after high-dose radiation
with subsequent delayed demyelinization [62]; microglial
cells, which are mature cells that continue to divide in
the CNS and are decreased in the spinal cord of irra-
diated rats [63]; neural stem cells giving rise to adult-
born neurons [64]. At present there is consensus that
adult neurogenesis occurs in two main areas (Figure 4)
of the human brain: the subgranular zone (SGZ) of the
dentate gyrus (DG) of the hippocampus, where new
granule generated neurons have been associated with
learning/memory and mood modulation, and the sub-
ventricular zone (SVZ), from which newborn cells mi-
grate through the rostral migratory stream and give rise
to newly generated neurons in the olfactory bulb [65,66].
Adult neural stem cells are highly sensitive to radiation
even at chronic, moderate doses [67-70]. For example,
with a cumulative dose of 0.5 Sv, in a mouse model, re-
petitive exposure more closely mirroring the model of
professional exposure had a much more pronounced ef-
fect on cellular neurogenesis than acute exposure [70].
Reduction/arrest of adult neurogenesis in the hippocampus
by low targeted X-irradiation impairs cognitive tests related
to hippocampal memory [71,72]. Acute irradiation withsublethal dose causes reduction of cell proliferation and
morphological alterations in the olfactory bulb with succes-
sive development of gliosis [73]. Interestingly, focal SVZ ir-
radiation reduced the proliferation rate of newly generated
olfactory neurons, thus resulting in long-term olfactory
memory dysfunction; these data suggest that newborn adult
neurons are involved in the memory of olfactory traces [74].
Previous studies suggested that radiation exposure might
represent a risk for schizophrenia in humans [75,76]. In
10,834 individuals irradiated in childhood for tinea capitis
(mean dose=1.5 Gy), no association was found between ra-
diation exposure and risk of schizophrenia, although for the
subgroup irradiated at< 5 years of age a trend was found
(hazard ratio=1.18, 95% CI=0.96–1.44, p=0.1) [75]. Re-
cent data showed that rats exposed to fractionated radiation
dose present reduction of neurogenesis in DG and SVZ
associated with schizophrenia-like behavior [77]. Finally, it
should be remarked that neural stem cells and microglial
cells can be impaired several years before clinically overt
neurodegenerative diseases such as sporadic Alzheimer’s
and Parkinson’s disease [66,78]. At a molecular level, the
major fundamental mechanism triggered in the irradiated
brain and responsible for structural alterations is DNA
damage followed by pro-oxidant, pro-inflammatory and
enhanced apoptotic response [79]. These effects have all
been described in circulating lymphocytes and plasma of
interventional cardiologists [80,81]. In the brain, apoptosis
of neuronal stem cells and reduction of their proliferation
rate following irradiation has been repeatedly associated
with cognitive deficits in adult mammals [70-73]. However,
the molecular substrate of cognitive impairment following
low-dose radiation is still debated; in particular, the question
of when and to what extent synaptic transmission/plasticity
is affected by fractionated radiation is by and large un-
answered. Previous results showed that hippocampal slices
undergo changes in neuronal excitability following moder-
ate doses of ionizing radiation [82]. More recently, in the
mouse brain, Silasi et al. [70] reported perturbations in cell
signaling associated with impairment of hippocampal
neurogenesis. This issue is becoming even more relevant
following recent observations by Mancuso et al. [25] on
changes occurring in unexposed regions neighboring
damaged cells, due to cell-to-cell communication or soluble
factors released by irradiated cells. Thus, an accurate inves-
tigation of fractionated vs acute radiation damage to neur-
onal/neural cells in different brain areas is needed in order
to understand the link between molecular mechanisms of
radiation-induced alterations and cognitive impairment.
This represents an important topic, since outside the field
of radiation therapy [83], the evidence linking radiation ex-
posure to cognitive disorders is weak, especially in the case
of occupationally exposed medical workers [76,78]. Yamada
et al. reported no relationship between radiation exposure
(< 4 Gy) and dementia in 2,286 aging atomic bomb
Figure 5 Scatter dose rate values during fluoroscopy in interventional cardiologists without protection (as is was standard practice in
many laboratories until some years ago). The use of lead cap protection or total body protection with radioprotection cabin or ceiling suspended
screen reduces the scatter dose to less than 1%. From the International Atomic Energy Agency collection of slides (Radiation Protection of Patients, on
the dedicated and continuously updated website: http://rpop.iaea.org.website), ref 96 (Kuon 2003) and ref. 18 (Dragusin, 2007).
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occupational exposures in the low-to-moderate dose range
(< 500 mSv). Death from dementia was significantly asso-
ciated with total lifetime radiation doses in 69,976 female
nuclear power plant workers [85], pre-senile dementia was
more frequent in dentists [86], and elevated mortality from
intentional self-harm, alcoholism and drowning was found
in 11,311 former US flight attendants [87]. In 100
Chernobyl liquidators and 100 patients who suffered the
acute radiation sickness in Chernobyl, schizophrenia-like
disorders were more frequent in presence of over- irradi-
ation (> 300 mSv) [88]. Mental disorders (including mental
retardation and behavioral disorders) were most frequent in
544 Chernobyl prenatally irradiated children (with an esti-
mated dose> 0.30 Sv to pregnant mothers) compared to
non-irradiated controls born in radioecological “clear”
regions [89]. There is no doubt that Chernobyl had an effect
on mental health of adults directly affected by the event, es-
pecially the liquidators and women with young children,
which is why the 2006 Chernobyl Forum report regarded
mental health as the major public health consequence [90].
However, the scope and magnitude of the mental healtheffects cannot be specified with the data at hand [91]. The
interpretation of these findings remains difficult due to con-
founding factors such as environmental mental stress, other
possible chemical or physical contaminants in work habitat,
night shift, and socio-economic confounders. Radiation is
only a potential - but unproven - source of bioeffects, but
certainly more data are warranted [92].
Other non-cancer effects: cataract
The radiation protection standards formulated by the
United States National Council on Radiation Protection and
Measurements (NCRP) and the International Commission
on Radiological Protection (ICRP) are all based on the belief
that lens opacities (cataracts) are deterministic radiation-
induced effects and appear only if a dose threshold is
exceeded. Cataract, or opacification of the lens, is often
associated with visual impairment and may be classified into
three main categories: nuclear, cortical, and posterior sub-
capsular, according to their anatomic location [93]. Among
the three major areas of age-related cataracts, posterior sub-
capsular is the least common but it is the one most fre-
quently associated with ionizing radiation exposure. The
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known. There is a transparent layer of cells covering the in-
terior frontal side of the capsule that covers the lens. This
layer maintains the function of the lens by slowly growing
toward the center, achieved through cell division at the per-
iphery. Because radiation is especially harmful to dividing
cells, exposed cells at the equator are most prone to dam-
age. For unknown reasons, damaged cells move toward the
rear of the lens before converging on the center. Such cells
prevent light from travelling straightforward resulting in
opacity. Because of their location along the lens’ visual axis,
relatively minor posterior subcapsular cataracts can have
great impact on vision. The estimated eye dose is around
0.5 mGy/procedure, when no eye protection is used. Until
recently, the dose threshold for radiation-induced lens opa-
cities were considered 2 Gy for a single dose or 5 Gy for
fractionated dose [94]. However, several epidemiological
studies among Chernobyl clean-up workers, A-bomb survi-
vors, astronauts, residents of contaminated buildings, and
surveys of staff in interventional rooms indicate that there
is an increased incidence of lens opacities at doses below
0.5 Gy and even suggest a stochastic hypothesis (non-
threshold effect) [95]. Whether deterministic or stochastic
in nature, cataracts can be found in up to 50% of interven-
tional cardiologists [96].
The reasons for this high prevalence are threefold: first
is that operator’s eyes are exposed to scattered x-rays.
Without lead protection, the operator’s eyes receive a
mean entrance skin dose of 165 μSv per coronary angi-
ography session, but the use of lead eyeglasses reduces
this level to 37 μSv [96]. Second (avoidable) is the fre-
quent failure of some cardiologists to use protective
leaded eyewear [68]; and probably third, that the allowed
occupational dose limits were too high to even keep an
alert in mind. On April 21, 2011, ICRP slashed the earl-
ier dose limit of 150 mSv in a year for the lens of the eye
to the present 20 mSv in a year, averaged over a defined
period of 5 years, with no single year exceeding 50 mSv
[9].
The unique model of interventional cardiologists and x-
ray exposure: mind the brain!
First-generation interventional cardiologists who entered
the catheterization laboratory 20 to 30 years ago were
inclined to believe that radiation is not such a serious mat-
ter [21], and in particular that the brain is a radio-resistant
organ, that the eye lens can tolerate high doses of radiation,
that no significant mitotic activity is present in the adult
brain, and that no biologically plausible effect can link x-ray
exposure to non-cancer disease such as neurovascular and
neurodegenerative disorders. Unfortunately, all these
assumptions have been disproved in the last decades. As a
consequence, operators in catheterization laboratories
should modify the habit of not using personal protectivegarments to shield their forehead and brain. The first line
of whole-body defence against unwanted effects of radiation
exposure is to start implementing the principles of justifica-
tion and optimization in the catheterization lab. The second
line of defence is to strictly adhere to protection practice
(Figure 6). The use of a ceiling-suspended screen [21] or
0.5 mm lead cap attenuates scatter dose to the head by a
factor of 2000 of baseline [96]. The radioprotection cabin
reduces the head dose from over 100 μSv per procedure to
the environmental background level of 1 μSv per procedure
[18]. The third action is to start to look systematically to
health (including brain) effects on the interventional cardi-
ologist and staff population, which may become a Rosetta
stone for decoding the long-term effects of radiation ex-
posure, a recognized major environmental pollutant in the
contemporary environment [97]. Contemporary invasive
cardiologists and interventional radiologists are therefore a
suitable research model for addressing many unanswered
questions on the link between radiation exposure and
proven but still imprecisely defined (eye cataract or brain
cancer), probable (vascular) and possible (neuro-cognitive)
serious health effects. In fact, two major studies on
interventional cardiologists, invasive radiologists and
catheterization laboratory staff are now at the starting
blocks: the North American and the Italian studies
(Table 3). The Multispecialty Occupational Health Group
(MOHG) undertook a cohort mortality study comparing
cancer and other serious disease outcomes (including car-
diovascular disease and cataracts) in 44,000 physicians per-
forming fluoroscopically guided procedures (including
interventional cardiologists, radiologists, neuroradiologists
and others) and in 12,000 non-interventional radiologists
with risks in 101,000 physicians who are unlikely to be
exposed to occupational radiation (e.g., family physicians
or psychiatrists) [98]. Member organizations of the
MSOHG include the Society of Cardiac Angiography and
Intervention, Society of Interventional Radiology, Heart
Rhythm Society, American College of Radiology, American
College of Cardiology, Society of Neurointervention
Surgery, American Association of Physicists in Medicine,
and Society of Invasive Cardiac Professionals. The
MSOHG is collaborating with experts in occupational
health, epidemiology, and radiation effects who are from
the United States Navy and the Radiation Epidemiology
Branch of the National Cancer Institute, to perform epi-
demiological studies addressing the fundamental questions
important to all those working in such an environment.
In Italy, The Healthy Cath Lab study is organized by the
Italian National Research Council with endorsement of
the Italian Society of Invasive Cardiologists, and is
designed by interventional cardiologists for interventional
cardiologists. The Italian study population will consist of
500 exposed (high, medium, and low exposure) interven-
tional cardiologists and staff (technicians and staff) and
Figure 6 Scatter dose rate values during fluoroscopy in interventional cardiologists without protection (as is was standard practice in
many laboratories until some years ago). The use of lead cap protection or total body protection with radioprotection cabin or ceiling suspended
screen reduces the scatter dose to less than 1%. From the International Atomic Energy Agency collection of slides (Radiation Protection of Patients, on
the dedicated and continuously updated website: http://rpop.iaea.org.website), ref 96 (Kuon 2003) and ref. 18 (Dragusin, 2007).
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With this limited sample size, the detection of potentially
increased health risks remains difficult using the epi-
demiological approach. Therefore, as an alternative to the
epidemiological approach, the Healthy Cath Lab study will
assess brain effects though “early warning signs”, which
evaluate initial damage through surrogate endpoints that
are easy to measure, non-invasive, and able to identify
long-term risk for subsequent clinically overt disease.
Other effects evaluated in the study are endocrine, repro-
ductive, and atherosclerotic functions. Examples of surro-
gate end-points adopted in the study are carotid-intima
media thickness for cerebrovascular atherosclerotic disease
[99], olfactory dysfunction for neurodegenerative disorders
[100], and circulating plasma brain-derived neurotrophin,
which is directly linked to hippocampal neurogenesis and
is reduced in pre-depressive and neurodegenerative condi-
tions [101]. Both the North American and Italian studies
will bring the safety issue center stage and are destined toTable 3 Ongoing studies on interventional cardiologists
Main funding NIH and NCI
Scientific Societies endorsement Multispecialty Occupational Health
Enrolled population • 44,000 fluoroscopists (interventiona
radiologists, neuroradiologists)
• 42,000 non-interventional radiolog
• 101,000 non-exposed physicians
Endpoint Epidemiological clinical endpoints (
vascular events)increase awareness of ionizing radiation in the
catheterization laboratory and generate relevant data for
better understanding of the most serious health effects of
professional chronic low-dose radiation exposure, eventu-
ally bridging the experimental and epidemiological divide
between high-dose (radiotherapy) and chronic low- to
moderate doses (professional exposure) [102]. Taken to-
gether, these studies should remind the interventional car-
diology community that “the responsibility of all
physicians is to minimize the radiation injury hazard to
their patients, to their professional staff and to themselves”
[103].
Conclusions
The brain is among the most critical dose-limiting
organs in radio-therapy, mainly due to the development
of cognitive dysfunction following white matter disrup-
tion. The neuro-vascular unit is also vulnerable to radi-
ation effects, and cerebro-vascular atheroscleroticItalian CNR National Research Council-IFC,
Institute of Clinical Physiology
Group Italian Society of Invasive Cardiology (GISE)
l cardiologists,
ists
• 500 exposed interventional cardiologists (nurses,
technicians)
• 500 non exposed clinical cardiologists (nurses,
technicians)
cancer, cataract, Surrogate biomarkers of genetic, vascular,
reproductive, cognitive effect
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evidences for doses> 500 mSv. The head doses involved
in radiotherapy are high, usually above 2 Sv, whereas the
low-dose range of professional exposure typically
involves lifetime cumulative whole-body exposure in the
low-dose range of< 200 mSv, but with head exposure
which may (in absence of protection) arrive at a head
equivalent dose of 1 to 3 Sv after a professional lifetime
(corresponding to a brain equivalent dose around
500 mSv). At this point, a systematic assessment of brain
(cancer and non-cancer) effects of chronic low-dose radi-
ation exposure in interventional cardiologists and staff is
needed.
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